Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine vs atenolol in chronic stable angina
CTR20132189Phase 3Active
- Sponsor
- Changzhou Siyao Pharmaceuticals
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in angina pectoris, sponsored by Changzhou Siyao Pharmaceuticals. Started Jan 2014; status: active.
02
Drugs
ivabradine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on CTR20132189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132189.